Bluejay Diagnostics, Inc. Operating Cash Flow
Bluejay Diagnostics, Inc. (BJDX) reported Operating Cash Flow of -$3.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.50M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.59M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.45M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.36M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$6.05M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$7.82M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$8.31M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$7.74M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.09M 10-Q · filed 2026-08-12 | -$4.54M derived: sum of 3 quarters · filed 2026-08-12 | -$5.90M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$1.59M 10-Q · filed 2026-05-07 | -$3.04M derived: sum of 2 quarters · filed 2026-05-07 | -$4.40M derived: sum of 3 quarters · filed 2026-05-07 | -$6.46M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$2.81M derived: sum of 2 quarters · filed 2026-03-06 | -$4.87M derived: sum of 3 quarters · filed 2026-08-12 | -$6.05M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$3.41M derived: sum of 2 quarters · filed 2026-08-12 | -$4.60M 10-Q · filed 2025-11-07 | -$6.05M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.24M 10-Q · filed 2026-08-12 | -$4.69M derived: sum of 3 quarters · filed 2026-08-12 | -$6.84M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$1.18M 10-Q · filed 2026-05-07 | -$2.64M derived: sum of 2 quarters · filed 2026-05-07 | -$4.79M derived: sum of 3 quarters · filed 2026-05-07 | -$6.71M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$3.61M derived: sum of 2 quarters · filed 2026-03-06 | -$5.52M derived: sum of 3 quarters · filed 2026-03-06 | -$7.82M 10-K · filed 2026-03-06 | -$7.82M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.07M derived: sum of 2 quarters · filed 2025-11-07 | -$6.37M 10-Q · filed 2025-11-07 | -$6.08M 10-Q · filed 2024-11-07 | -$9.15M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.21M 10-Q · filed 2025-08-07 | -$4.15M 10-Q · filed 2024-08-14 | -$6.99M derived: sum of 3 quarters · filed 2025-08-07 | -$8.12M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$2.30M 10-Q · filed 2025-05-13 | -$2.30M 10-Q · filed 2024-05-15 | -$5.08M derived: sum of 2 quarters · filed 2025-05-13 | -$6.20M derived: sum of 3 quarters · filed 2025-05-13 | -$7.68M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.90M derived: sum of 2 quarters · filed 2025-03-31 | -$5.38M derived: sum of 3 quarters · filed 2025-03-31 | -$8.31M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.60M derived: sum of 2 quarters · filed 2024-11-07 | -$5.54M 10-Q · filed 2024-11-07 | -$8.48M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.41M 10-Q · filed 2024-08-14 | -$7.36M derived: sum of 3 quarters · filed 2024-08-14 | -$8.62M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$2.93M 10-Q · filed 2024-05-15 | -$5.88M derived: sum of 2 quarters · filed 2024-05-15 | -$7.14M derived: sum of 3 quarters · filed 2024-05-15 | -$8.80M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$4.21M derived: sum of 2 quarters · filed 2024-03-28 | -$5.86M derived: sum of 3 quarters · filed 2024-03-28 | -$7.74M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.92M derived: sum of 2 quarters · filed 2023-11-09 | -$4.80M 10-Q · filed 2023-11-09 | -$7.32M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$3.54M 10-Q · filed 2023-08-14 | -$6.06M derived: sum of 3 quarters · filed 2023-08-14 | -$7.17M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$1.88M 10-Q · filed 2023-05-11 | -$4.40M derived: sum of 2 quarters · filed 2023-05-11 | -$5.52M derived: sum of 3 quarters · filed 2023-05-11 | -$5.87M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$3.64M derived: sum of 2 quarters · filed 2023-03-20 | -$3.99M derived: sum of 3 quarters · filed 2023-03-20 | -$4.37M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.47M derived: sum of 2 quarters · filed 2022-11-09 | -$1.84M 10-Q · filed 2022-11-09 | -$2.00M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$356.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$728.80K 10-Q · filed 2022-08-10 | -$883.66K derived: sum of 3 quarters · filed 2022-08-10 | |||||
| 2021-03-31 | -$372.62K 10-Q · filed 2022-05-09 | -$527.48K derived: sum of 2 quarters · filed 2022-05-09 | ||||||
| 2020-12-31 | -$154.86K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$508.71K 10-K · filed 2022-03-10 | ||||||
| 2020-09-30 | -$353.85K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |